XML 18 R4.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Revenues      
Total revenues $ 1,082,571 $ 820,222 $ 625,486
Cost and expenses      
Research and development 320,678 316,415 264,208
Selling, general and administrative 618,307 588,591 511,034
Total cost and expenses 1,528,816 1,361,262 1,093,660
Loss from operations (446,245) (541,040) (468,174)
Interest expense (12,638) (9,319) (8,305)
Interest and other income, net 24,353 3,538 5,381
Loss before income taxes (434,530) (546,821) (471,098)
Income tax expense (271) (978) (618)
Net loss (434,801) (547,799) (471,716)
Unrealized gain (loss) on available-for-sale securities, net of tax 13,277 (14,075) (6,546)
Comprehensive loss $ (421,524) $ (561,874) $ (478,262)
Net Loss per Share      
Basic (in dollars per share) $ (3.78) $ (5.57) $ (5.21)
Diluted (in dollars per share) $ (3.78) $ (5.57) $ (5.21)
Weighted-average number of shares used in computing basic and diluted net loss per share:      
Basic (in shares) 114,997 98,408 90,558
Diluted (in shares) 114,997 98,408 90,558
Product      
Revenues      
Total revenues $ 1,068,522 $ 797,307 $ 580,080
Cost and expenses      
Cost of revenues 588,564 453,632 315,195
Licensing and other      
Revenues      
Total revenues 14,049 22,915 45,406
Cost and expenses      
Cost of revenues $ 1,267 $ 2,624 $ 3,223